208 related articles for article (PubMed ID: 18650171)
21. Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer.
Gore EM
Oncology (Williston Park); 2003 Jun; 17(6):775-9; discussion 779-80, 784, 787 passim. PubMed ID: 12846122
[TBL] [Abstract][Full Text] [Related]
22. Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation.
Senzer N
Semin Oncol; 2002 Dec; 29(6 Suppl 19):47-52. PubMed ID: 12577244
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.
Lee JS; Pisters KM; Komaki R; Glisson BS; Khuri FR; Schea R; Fossella FV
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-52-S12-55. PubMed ID: 9331122
[TBL] [Abstract][Full Text] [Related]
24. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.
Guerrieri M; Wong K; Ryan G; Millward M; Quong G; Ball DL
Lung Cancer; 2004 Oct; 46(1):107-11. PubMed ID: 15364138
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic cranial irradiation in small-cell lung cancer.
Fujiwara Y; Hotta K; Kiura K
N Engl J Med; 2007 Nov; 357(19):1977-8; author reply 1978. PubMed ID: 17992731
[No Abstract] [Full Text] [Related]
26. Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer.
Gore E
Clin Lung Cancer; 2006 Jan; 7(4):276-8. PubMed ID: 16512983
[No Abstract] [Full Text] [Related]
27. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
[TBL] [Abstract][Full Text] [Related]
28. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
Shi AH; Zhu GY; Yu R; Ma HM; Liu CQ; Su X; Sun Y; Cai Y; Xu XN; Zhang SW; Xu B
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):545-8. PubMed ID: 18069640
[TBL] [Abstract][Full Text] [Related]
29. Multimodality management of non-small cell lung cancer patients with brain metastases.
Ricciardi S; de Marinis F
Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
[TBL] [Abstract][Full Text] [Related]
30. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
31. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
32. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
Gaspar LE; Chansky K; Albain KS; Vallieres E; Rusch V; Crowley JJ; Livingston RB; Gandara DR
J Clin Oncol; 2005 May; 23(13):2955-61. PubMed ID: 15860851
[TBL] [Abstract][Full Text] [Related]
33. [Prophylactic cranial irradiation: a new standard for all responding patients with small cell lung cancer].
Groen HJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):984-6. PubMed ID: 18549171
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer and its operable brain metastasis: survival rate and staging problems.
Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
[TBL] [Abstract][Full Text] [Related]
35. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
[TBL] [Abstract][Full Text] [Related]
36. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
37. Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation?
Gore E; Choy H
Semin Radiat Oncol; 2004 Oct; 14(4):292-7. PubMed ID: 15558503
[TBL] [Abstract][Full Text] [Related]
38. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
40. An update on the treatment of CNS metastases in small cell lung cancer.
Castrucci WA; Knisely JP
Cancer J; 2008; 14(3):138-46. PubMed ID: 18536552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
